Hyperkinetic movement disorders are. Hyperkinetic Movement Disorders. Cases in Movement Disorders. James case. About Tom

Similar documents
Professor Tim Anderson

STAFF DEVELOPMENT in SPECIAL EDUCATION

What is Tourette Syndrome?

Professor Tim Anderson

Enhanced Primary Care Pathway: Parkinson s Disease

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else?

Tourette Syndrome Part 1

Movement Disorders. Eric Kraus, MD! Neurology!

Issues for Patient Discussion

Obsessive-Compulsive Disorder

Externalizing Disorders

Tourette syndrome What is Tourette syndrome? What are the symptoms? What is the course of TS? Can people with TS control their tics? What causes TS?

Approach to Tremor in Older Adults

Understanding Parkinson s Disease Important information for you and your loved ones

Your reference guide for the most common movement disorder

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Tremor 101. Objectives 9/30/2015. Importance of tremors

Prior Authorization with Quantity Limit Program Summary

Understanding. Tremor. Christy, diagnosed with essential tremor in childhood, with her husband, Ben.

There are two categories of TS tics and several of the more common examples are:

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department

Optimizing Clinical Communication in Parkinson s Disease:

Childhood Movement Disorders Alessandro Capuano, MD, PhD Federica Graziola, MD

Questions and Answers to help you better understand Tourette Syndrome. Misunderstood, misdiagnosed, and much more common than you think

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

Moving fast or moving slow: an overview of Movement Disorders

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Medication Management in Tic Disorders. Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18

Basal ganglia Sujata Sofat, class of 2009

Parkinson s Disease. Sirilak yimcharoen

Extrapyramidal Symptoms Associated with Antipsychotic Use

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

CONTRIBUTORS The American Academy of Neurology Institute.

AAN Summary for Public Comment DRAFT Guideline: Treating Tics in Tourette Syndrome and Chronic Tic Disorders

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Evaluation of Parkinson s Patients and Primary Care Providers

DEEP BRAIN STIMULATION

Studying with tic disorder Facts & Figures, Focus points, Tips and Tricks

Evaluation and Management of Parkinson s Disease in the Older Patient

Essential Tremor Patient Handbook. Your reference guide for the most common movement disorder.

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS)

10th Medicine Review Course st July Prakash Kumar

EMERGING TREATMENTS FOR PARKINSON S DISEASE

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Case Report Neuropsychiatric Outcome of an Adolescent Who Received Deep Brain Stimulation for Tourette s Syndrome

Objectives TOURETTE SYNDROME IN THE PEDIATRIC POPULATION. Gilles de la Tourette Syndrome. Most famous. Definition of Tourette s.

Tremor, Rigidity, Tics and Dystonia: The 4 Most Common Movement Disorders

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Movement disorders. Dr Rick Leventer Royal Children s Hospital

Dr. Alan Carroll MB, BCh, MRC Psych. FRCP(C) Psychiatrist, Clinical Professor of Psychiatry, University of Alberta Glenrose Rehabilitation Hospital

movement disorders for psychiatrists

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

Over the last 20 years, Deep Brain Stimulation (DBS)

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.

Tremor What is tremor? What causes tremor? What are the characteristics of tremor? What are the different categories of tremor?

Understanding Tremor Diagnosis, Cause, Treatment. Monique Giroux, MD Englewood and Fort Collins, CO

SHARED CARE GUIDELINE

316 Index. 225, 229, 232, 238, 242, 285, 293, 307, 309 dyskinesias, 54,295 dystonias, 54

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Assessing a Tremor. Tremor diagnosis and Treatment. Outline. Chorea. Assessing a Tremor. Tics 4/10/2012

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Update on Parkinson s disease and other Movement Disorders October 2018

Deep Brain Stimulation: Patient selection

III./3.1. Movement disorders with akinetic rigid symptoms

Alison Charleston 1 st September 2016

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Children s TiPS Psychiatry: Diagnosis and Treatment of Tic Disorders in Primary Care By: Dr. Anna Jolliffe

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

AUSTEDO (deutetrabenazine) oral tablet INGREZZA (valbenazine) oral capsule XENAZINE (tetrabenazine) oral tablet Tetrabenazine oral tablet

Treatment of Parkinson s Disease: Present and Future

Tremor. Mario Zappia. Università degli Studi di Catania

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

Deep Brain Stimulation for Parkinson s Disease & Essential Tremor

Differential Diagnosis of Hypokinetic Movement Disorders

Cardinal Features of Parkinson s. Management of Parkinson s Disease. Drug Induced Parkinson s. Other Parkinson s Symptoms.

Xenazine. Xenazine (tetrabenazine) Description

Deep Brain Stimulation: Indications and Ethical Applications

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Copyright 2009 ACNN 1

A Four Point Plan for Enhanced Support for Parkinson s Disease In B.C.

Deep Brain Stimulation. Is It Right for You?

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Semivoluntary movement (=unvoluntary)

Xenazine. Xenazine (tetrabenazine) Description

Parkinson s Disease. Gillian Sare

DYSKINESIA SYMPTOM TRACKER

Headway Victoria Epilepsy and Parkinson s Centre

Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB

An Approach to Patients with Movement Disorders

Dopamine Depleting Drugs

Transcription:

Hyperkinetic Movement Disorders Sarah Furtado, MD, PhD, FRCPC James case A mother brings her son James, 10, to your office because of repetitive sniffing sounds and repetitive eye blinking. This sniffing has been going on for about a year, but seems to wax and wane; it is worse prior to tests at school and while at home in the evenings, but it was better last summer, when James was away from school. James admits he tends to prevent his sniffing while at school and lets things out while he is at home. Thinking back, James may have had a period of repetitive grunting in the past year, but this is no longer a problem. James admits to having a very neat and tidy room at home, unlike his friends. Nevertheless, he does well in school and has many friends. James father is very neat and tidy like his son and may also have the same tendency to excessive sniffing. Your exam of James is essentially normal, except for repetitive eye blinking and mild sniffing. About Tom Tom, 60, is right-handed. He presents to your office with tremor. He is concerned that he has Parkinson s disease (PD), as there is a family history of tremor. He says that he has had his tremor for about 5 years and wonders if it is getting worse. He notices the tremor primarily when he holds objects; there is no tremor at rest. The tremor is improved when he consumes wine or beer. His handwriting is described as slightly shaky, but not smaller, and is still legible. Exam discloses a well-looking man with no head tremor and good facial expression and voice volume. He is also found to have fine tremor in both hands immediately present on holding both arms outstretched and on holding a cup; however, there is no tremor at rest and no evidence of slowness. He has normal tone and an otherwise normal neurologic exam. You have him write a sentence or two in the office and his handwriting is of normal size, but slightly shaky. For more on Tom, go to page 59. Hyperkinetic movement disorders are characterized by excess of movement and may be classified as certain tremors, chorea/dyskinesia, dystonia, and tics. The family doctor will likely encounter some of these movement disorders in his/her practice. 58 The Canadian Journal of CME / April 2004

More on Tom Tom returns to your office. His metabolic workup for tremor has been normal. He is not taking any medications that might cause tremor. On the followup visit, he does not find the tremor very disturbing and would prefer to live without medications aimed at treating his tremor. He is very relieved when you inform him, on the first visit, that he does not have Parkinson s disease, but essential tremor. How is postural tremor different from Parkinson s disease? Postural tremor is probably the most common movement disorder likely to be encountered by the family doctor. It is a tremor that is present in the hands when the arms and hands are held outstretched or when the patient holds objects, such as a cup. No rest tremor is typically present in a patient with postural tremor and this important abscence, as well as the absence of other signs of Parkinson s disease (PD) helps the doctor distinguish postural tremor from PD (Table 1). Bob s Parkinson s disease Bob, 65, presents with Parkinson s disease diagnosed by a neurologist 8 years ago. He continues to be managed by his neurologist. He has responded well to levodopa and a dopaminergic agonist over the years; this treatment has improved his now bilateral resting tremor and slowness (bradykinesia) significantly. Recently, Bob has become concerned that his tremor is becoming worse and he has tried to increase his levodopa consumption. Unfortunately, this does not seem to help. He is now bothered by his movements, which seem to be bad several hours after taking his last levodopa tablets, and then improve in the hours leading up to his next dose of levodopa. When you examine Bob, 2 to 3 hours after his last dose of levodopa, you find his exam predominated by extra, involuntary movements in his trunk and legs. These are moderately disruptive to him and there is really no evidence of resting tremor or bradykinesia. What are the causes of postural tremor? When the differential diagnosis of a postural tremor is made, and when other disorders are excluded (a metabolic or druginduced tremor), if there is a family histo- Dr. Furtado is a clinical assistant professor, Movement Disorders Clinic, department of clinical neurosciences, University of Calgary, Calgary, Alberta.

ry of tremor that is responsive to alcohol, the diagnosis of essential tremor is made (Table 2). How should essential tremor be treated? Table 1 Features distinguishing postural tremor from Parkinson s disease Essential tremor Parkinson s disease Tremor Present with holding objects; Tremor at rest; no tremor no tremor at rest with holding objects Family history Common May be present Response to Often improves tremor No improvement of tremor alcohol In many patients, medications are not necessary. However, if the tremor is bothersome and interferes with daily activities, first-line medications include propanolol (up to 240 mg/day in divided doses, or other beta blockers) or primidone (up to 250 mg/day in divided doses). Beta blockers are contraindicated in people with asthma and/or diabetes. Common sideeffects of beta blockers include fatigue, hypotension, and depression. Common side-effects of primidone include dizziness and fatigue. If these two first-line medications are unsuccessful, other medications, including gabapentin, topiramate, and even mirtazapine, can be tried. In those few patients who do not respond to medications, but need treatment, surgery may be considered. Creation of a discrete lesion in the thalamus (thalamotomy) or placement of a deep brain stimulator in the thalamus (thalamic stimulation) may prove beneficial in severe cases. Other signs Head tremor Slowness of movement, cogwheel rigidity, soft voice, decreased facial expression Shaky handwriting; normal size What are tics? Small handwriting (micrographia) Table 2 Differential diagnosis of postural tremor Essential tremor Hyperthyroidism Renal failure Liver failure Drug-induced tremor (e.g., lithium, valproate) Dystonia Tics are brief, repetitive, stereotyped movements, such as eyeblinking or grimacing; vocal tics can include throat clearing or grunting. Patients may describe some sort of sensory premonition prior to tic onset; they may have the ability to suppress tics in certain social situations, but also have the need to let them out later, in a socially supportive situation. 60 The Canadian Journal of CME / April 2004

Table 3 Treatment of tics, ADHD, and obsessive compulsive tendencies A. Treatment of tics Supportive: Education of family, teachers, and friends Pharmacologic: Clonidine, 0.1 mg bid-tid Tetrabenazine, 25 mg tid Quetiapine, 25 mg bid-tid Pimozide Haloperidol B. Treatment of ADHD Dexedrine Methylphenidate C. Treatment of obsessive compulsive tendencies SSRIs bid: Twice daily ADHD: Attention deficit hyperactivity disorder tid: Three times daily SSRIs: Selective serotonin reuptake inhibitors understanding of family and teachers. It must be understood that tics are a part of a medical condition, and not an attempt to disrupt the family or classroom. It should also be recognized that tics wax and wane in severity throughout the year. 2. Second, treatment of tics should be initiated only when tics are severe enough to disrupt school or home life. Treatment should not be initiated because those surrounding the child feel uncomfortable with the tics. In general, treatment of tics starts with clonidine, then quetiapine or tetrabenazine (the prescription of tetrabenazine may need special approval). Higher potency neuroleptics, such as pimozide or haloperidol, may be used if these initial medications are not helpful and tics are severe. What is Tourette s syndrome (TS)? TS is characterized by multiple motor and one or more vocal tics, onset of tics prior to the age of 18, and presence of tics for more than one year; other causes of tics, such as drugs, infections, or other neurologic disorders, should be excluded. Associated features may include attention deficit hyperactivity disorder (ADHD) and obsessive compulsive traits. Boys are more affected than girls and male members of the family may be affected with some or all of these symptoms and signs. How should TS be treated? Treatment of TS is multifaceted. 1. First, it is important to garner the

Table 4 Dyskinesia versus resting tremor and bradykinesia in Parkinson s disease Dyskinesia Writhing, involuntary movements; affecting legs and trunk Usually no associated bradykinesia Peak dose dyskinesias come on several hours after last dose of levodopa However, use of these latter medications carries the risk of tardive disorders later in life. The symptoms of ADHD are typically treated with stimulants, such as dexedrine or methylphenidate, and symptoms of obsessive compulsive tendencies are treated with selective serotonin reuptake inhibitors (Table 3). Complicated cases of TS are best managed with the help of a movement disorders neurologist or pediatric neurologist and pediatric psychiatrist. However, many children outgrow their tics by adulthood, although a period of worsening during puberty may be expected. PD and drug-induced dyskinesia Resting tremor Rhythmic, low frequency tremor at rest; can affect arms, legs, or chin Associated bradykinesia (slowness) Improvement in resting tremor and bradykinesia soon after medications PD is traditionally classified as a hypokinetic movement disorder because of the bradykinesia associated with the condition. However, the drugs used to treat PD can produce extra, involuntary writhing movements called dyskinesias. Dyskinesias are quite different from the resting tremor and bradykinesia characteristically associated with the disorder. It is important to encourage patients to distinguish dyskinesia from resting tremor. Furthermore, the treatment of dyskinesia is quite different from the treatment of bradykinetic symptoms and signs (Table 4). How should dyskinesias be treated? In general, dyskinesias associated with moderate PD are peak dose dyskinesias and come on several hours after the last dose of levodopa. These involuntary writhing movements in the legs and trunk gradually improve, and are eventually replaced by resting tremor and slowness of movement as time to the next dose of levodopa approaches. This type of dyskinesia may be treated by reducing the individual doses and increasing the frequency of doses of levodopa. Other approaches are to add a dopaminergic agonist, with reduction in levodopa dosages, or to add amantadine. If dyskinesias are mild and not bothersome, no change in medications is needed. However, as PD patients progress in their disease, other dyskinesia may occur, requiring different management. Patients who fulfill certain specific criteria may be considered for surgery (i.e., subthalamic nucleus stimulator placement). In cases of advanced PD, ongoing care through a neurologist with special expertise in PD will be of benefit to the patient. CME 62 The Canadian Journal of CME / April 2004

Suggested Readings 1. Furtado S, Pfeiffer RF, Uitti RJ et al: Neurotherapeutics and Movement Disorders. World Federation of Neurology Web site.www.wfneurology.org/research_advances_neurology.htm 2. Grimes, DA: Tremor-easily seen but difficult to describe and test. Can J Neurol Sci 2003; 30(Suppl 1):S59-63. 3. Martin WR, Wieler M: Treatment of Parkinson s Disease. Can J Neurol Sci 2003; 30(Suppl 1):S27-33. www.stacommunications.com For an electronic version of this article, visit: The Canadian Journal of CME online. Take-home message Tremor When the differential diagnosis of postural tremor is made and other disorders are excluded, if there is family history of tremor responsive to alcohol, diagnosis of essential tremor is made. First-line treatments for essential temor are propanolol and primidone. Surgery may be considered. TS Treatment for TS starts with clonidine, followed by quetiapine or tetrabenazine. Dyskinesias Dyskinesias are associated with moderate PD. Dyskinesias can be treated by reducing the doasge of levadopa, while increasing the frequency of dosing Advanced PD requires specialist referral.